跳至主要内容
临床试验/CTRI/2009/091/000119
CTRI/2009/091/000119已完成3 期

A Randomized, Double-Blind, Placebo-Controlled Parallel Group Efficacy and Safety Study of BI 1356 (5 mg Administered Orally Once Daily) Over 18 Weeks in Type 2 Diabetic Patients With Insufficient Glycaemic Control (HbA1c 7.0-10%) Despite Background Therapy With a Sulfonylurea Drug.

Boehringer Ingelheim0 个研究点目标入组 255 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
255

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients between 18 and 80 years old with type 2 diabetes and insufficient glycemic control (HbA1c 7% to 10%) despite therapy with a sulfonylurea drug
  • Age minimum: 18 Years
  • Age maximum: 80 Years
  • Gender: Both

排除标准

  • Myocardial infarction,stroke or transient ischaemic attack in last 6 months - Treatment with rosiglitazone, pioglitazone, GLP-1 analogues, insulin or anti-obesity drugs in the past 3 months - Impaired hepatic function - Severe renal impairment - Current treatment with systemic steroids - Change in thyroid hormone dosage - Hereditary galactose intolerance

研究者

相似试验

进行中(未招募)
不适用
A study in men with low testosterone to measure the effect of testosterone solution on testosterone levels, sex drive and energy.
EUCTR2012-004866-16-ITEli Lilly and Company618
进行中(未招募)
1 期
Arbaclofen Extended-Release Tablets for Treatment of Spasticity in Patients with Multiple SclerosisSpasticity in patients with multiple sclerosisMedDRA version: 20.0Level: LLTClassification code 10041416Term: SpasticitySystem Organ Class: 100000004852
EUCTR2017-004100-22-BGOsmotica Pharmaceutical US LLC510
招募中
不适用
A Randomized, Double-Blind, Placebo-Controlled Parallel Study with an Open-Label Extension to Assess the Impact of Testosterone Solution on Total Testosterone, Sex Drive and Energy in Hypogonadal MeDiseases of The genitoruinary system
KCT0001108Eli Lilly Korea50
进行中(未招募)
1 期
A study in men with low testosterone to measure the effect of testosterone solution on testosterone levels, sex drive and energy.Male hypogonadismMedDRA version: 14.1 Level: PT Classification code 10021011 Term: Hypogonadism male System Organ Class: 10014698 - Endocrine disorders
EUCTR2012-004866-16-GBEli Lilly and Company715
进行中(未招募)
1 期
A study in men with low testosterone to measure the effect of testosterone solution on testosterone levels, sex drive and energy.Male hypogonadismMedDRA version: 14.1Level: PTClassification code 10021011Term: Hypogonadism maleSystem Organ Class: 10014698 - Endocrine disorders
EUCTR2012-004866-16-DEEli Lilly and Company715